Bayview Pharmacy is pleased to present a specialized topical gel formulation of Flurbiprofen 10%/Cyclobenzaprine HCl 1%. This unique compound is specifically designed for the management of various musculoskeletal conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis.

Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID), functions by inhibiting the production of certain chemicals in the body that trigger inflammation and pain. On the other hand, Cyclobenzaprine HCl is a muscle relaxant that operates by blocking nerve impulses responsible for muscle spasms. The combination of these two medications in a gel form allows for targeted relief of pain and inflammation in the affected area.

This compounded formulation is a semisolid preparation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients. The gel-like consistency ensures that the medication is absorbed effectively into the skin, providing direct relief to the affected area.

The formulation can be applied up to four times a day for optimal results. However, it is crucial to remember that this formulation should not be used on broken or damaged skin. Additionally, patients with a history of gastrointestinal bleeding or ulcers should exercise caution when using this product.

If you have any queries about this Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel formulation or its application in treating Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, or Bursitis, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to assisting you in finding the most effective treatment option for your condition.

This Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel is a compounded formulation designed for targeted treatment of various conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis. The gel contains Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammation and pain-causing chemicals in the body. It also contains Cyclobenzaprine HCl, a muscle relaxant that blocks nerve impulses responsible for muscle spasms. The combination of these two active ingredients provides effective relief from pain and inflammation associated with the aforementioned conditions.

It is crucial to note that this formulation is contraindicated in patients with known hypersensitivity to either Flurbiprofen or Cyclobenzaprine HCl. It should also be avoided by patients with a history of gastrointestinal bleeding or ulcer disease. Patients are advised to avoid contact with the eyes and mucous membranes when applying the gel.

The gel should be applied to the affected area two to three times daily, or as directed by a healthcare provider. It is not recommended for use beyond two weeks without medical consultation. Patients should be aware that this medication may affect their alertness and should avoid activities requiring alertness until they understand how the medication affects them. Concurrent consumption of alcohol while using this medication is not advised as it may increase the risk of side effects.

If you have any questions about this Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel formulation or its use in treating Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, or Bursitis, please do not hesitate to reach out for further information.

This Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel is a semisolid formulation designed for targeted treatment of various conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis. The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin.

Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the production of certain chemicals in the body that cause inflammation and pain. Cyclobenzaprine HCl, on the other hand, is a muscle relaxant that functions by blocking nerve impulses that lead to muscle spasms. When combined and applied topically, these medications can effectively reduce inflammation and pain associated with the aforementioned conditions.

To use this topical gel, apply a thin layer to the affected area and gently massage until it is fully absorbed. It is crucial to wash your hands after applying the gel. Avoid applying the gel to broken or irritated skin and avoid contact with the eyes, nose, and mouth. Unless directed by your healthcare provider, do not cover the treated area with a bandage or other dressing.

Adherence to your healthcare provider’s instructions for using this medication is essential. Do not use more or less than prescribed and do not discontinue use without consulting your healthcare provider. If you have any questions or concerns about using this topical gel, do not hesitate to seek advice from a healthcare professional.

This compounded formulation of Flurbiprofen 10%/Cyclobenzaprine HCl 1% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, which allows for targeted treatment or absorption of the active ingredients. The gel-like consistency ensures that the medication is absorbed effectively through the skin, providing relief from a variety of musculoskeletal conditions. These include osteoarthritis, tendinitis, bursitis, fibromyalgia, and myofascial pain syndrome. It has also proven effective in treating muscle spasms, neck pain, and low back pain.

When using this formulation, it is crucial to apply it only to the affected area and not on open wounds or areas of skin that are broken or irritated. It is also important to avoid application on the face or around the eyes. After applying the gel, patients should wash their hands thoroughly to avoid accidental contact with the eyes. If any irritation or redness occurs, usage should be discontinued immediately and the healthcare provider should be contacted. This formulation is designed to provide targeted relief, and any adverse reactions should be reported promptly to ensure patient safety.